Jean‐Philippe Devissaguet

1.3k total citations
21 papers, 1.0k citations indexed

About

Jean‐Philippe Devissaguet is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Jean‐Philippe Devissaguet has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 6 papers in Molecular Biology and 5 papers in Biomaterials. Recurrent topics in Jean‐Philippe Devissaguet's work include Advanced Drug Delivery Systems (6 papers), Drug Solubulity and Delivery Systems (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Jean‐Philippe Devissaguet is often cited by papers focused on Advanced Drug Delivery Systems (6 papers), Drug Solubulity and Delivery Systems (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Jean‐Philippe Devissaguet collaborates with scholars based in France, Netherlands and Israel. Jean‐Philippe Devissaguet's co-authors include Gillian Barratt, Hatem Fessi, Denis Labarre, F. Puisieux, Vanessa Carla Furtado Mosqueira, Catherine Passirani, J.L. Morgat, Ruxandra Gref, Michel Vert and Catherine Passirani and has published in prestigious journals such as Journal of Colloid and Interface Science, Journal of Controlled Release and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jean‐Philippe Devissaguet

20 papers receiving 974 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Philippe Devissaguet France 14 547 333 278 173 145 21 1.0k
Dennis H. Robinson United States 18 361 0.7× 406 1.2× 248 0.9× 269 1.6× 71 0.5× 38 1.2k
J. Kreuter Germany 16 315 0.6× 305 0.9× 230 0.8× 165 1.0× 69 0.5× 36 803
Gro Smistad Norway 25 411 0.8× 555 1.7× 500 1.8× 235 1.4× 183 1.3× 60 1.7k
B. Benoit France 19 307 0.6× 335 1.0× 399 1.4× 136 0.8× 145 1.0× 44 1.8k
Noha M. Zaki Egypt 16 345 0.6× 576 1.7× 351 1.3× 128 0.7× 84 0.6× 25 1.3k
Tsugio Shimamoto Japan 15 405 0.7× 689 2.1× 376 1.4× 163 0.9× 92 0.6× 37 1.4k
Mats Reslow Sweden 13 558 1.0× 530 1.6× 621 2.2× 368 2.1× 133 0.9× 18 1.7k
Madeleine Besnard France 17 213 0.4× 304 0.9× 394 1.4× 112 0.6× 109 0.8× 23 991
Huguette Pinto‐Alphandary France 16 634 1.2× 548 1.6× 470 1.7× 271 1.6× 226 1.6× 19 1.6k
H. Süheyla Kaş Türkiye 16 336 0.6× 511 1.5× 182 0.7× 140 0.8× 73 0.5× 28 1.0k

Countries citing papers authored by Jean‐Philippe Devissaguet

Since Specialization
Citations

This map shows the geographic impact of Jean‐Philippe Devissaguet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Philippe Devissaguet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Philippe Devissaguet more than expected).

Fields of papers citing papers by Jean‐Philippe Devissaguet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Philippe Devissaguet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Philippe Devissaguet. The network helps show where Jean‐Philippe Devissaguet may publish in the future.

Co-authorship network of co-authors of Jean‐Philippe Devissaguet

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Philippe Devissaguet. A scholar is included among the top collaborators of Jean‐Philippe Devissaguet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Philippe Devissaguet. Jean‐Philippe Devissaguet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mosqueira, Vanessa Carla Furtado, Philippe M. Loiseau, Christian Bories, et al.. (2004). Efficacy and Pharmacokinetics of Intravenous Nanocapsule Formulations of Halofantrine in Plasmodium berghei -Infected Mice. Antimicrobial Agents and Chemotherapy. 48(4). 1222–1228. 77 indexed citations
2.
Mosqueira, Vanessa Carla Furtado, J.L. Morgat, Michel Vert, et al.. (2001). Biodistribution of Long-Circulating PEG-Grafted Nanocapsules in Mice: Effects of PEG Chain Length and Density. Pharmaceutical Research. 18(10). 1411–1419. 234 indexed citations
3.
Legrand, Philippe, Martine Appel, Sophie Gil, et al.. (2001). Reduction of NO Synthase Expression and Tumor Necrosis Factor Alpha Production in Macrophages by Amphotericin B Lipid Carriers. Antimicrobial Agents and Chemotherapy. 45(2). 553–562. 19 indexed citations
4.
Appel, Martine, et al.. (1999). Macrophage Activation by a Lipophilic Derivative of Muramyldipeptide within Nanocapsules: Investigation of the Mechanism of Drug Delivery. Journal of Nanoparticle Research. 1(1). 91–97. 11 indexed citations
5.
Passirani, Catherine, Gillian Barratt, Jean‐Philippe Devissaguet, & Denis Labarre. (1998). Long-Circulating Nanopartides Bearing Heparin or Dextran Covalently Bound to Poly(Methyl Methacrylate). Pharmaceutical Research. 15(7). 1046–1050. 144 indexed citations
6.
Passirani, Catherine, Gillian Barratt, Jean‐Philippe Devissaguet, & Denis Labarre. (1998). Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system. Life Sciences. 62(8). 775–785. 109 indexed citations
8.
Vauthier, Christine, et al.. (1996). In vitro degradation of nanospheres from poly(D,L-lactides) of different molecular weights and polydispersities. International Journal of Pharmaceutics. 129(1-2). 95–102. 109 indexed citations
9.
Appel, Martine, et al.. (1996). Relationship between no-synthase activity and TNF-α secretion in mouse macrophage lines stimulated by a muramyl peptide entrapped in nanocapsules. International Journal of Immunopharmacology. 18(6-7). 385–392. 6 indexed citations
10.
Egito, Eryvaldo Sócrates Tabosa do, et al.. (1996). In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system. Journal of Antimicrobial Chemotherapy. 38(3). 485–497. 18 indexed citations
11.
Fessi, Hatem, et al.. (1996). Freeze-drying of itraconazole-loaded nanosphere suspensions: a feasibility study. Drug Development Research. 38(2). 116–124. 61 indexed citations
12.
Fessi, Hatem, et al.. (1996). Freeze‐drying of itraconazole‐loaded nanosphere suspensions: a feasibility study. Drug Development Research. 38(2). 116–124.
13.
Fessi, Hatem, et al.. (1996). Comparative study of the association of itraconazole with colloidal drug carriers. Drug Development Research. 38(2). 125–133. 1 indexed citations
14.
Guterres, Sı́lvia Stanisçuaski, Hatem Fessi, Gillian Barratt, F. Puisieux, & Jean‐Philippe Devissaguet. (1995). Poly(D,L-Lactide) Nanocapsules Containing Non-Steroidal Anti-Inflammatory Drugs: Gastrointestinal Tolerance Following Intravenous and Oral Administration. Pharmaceutical Research. 12(10). 1545–1547. 39 indexed citations
15.
Vauthier, Christine, et al.. (1994). Adsorption of Allergen Extracts onto Colloidal Particles. Journal of Colloid and Interface Science. 166(2). 294–301. 3 indexed citations
16.
Fawaz, Fawaz, et al.. (1993). Influence of Poly(DL-Lactide) Nanocapsules on the Biliary Clearance and Enterohepatic Circulation of Indomethacin in the Rabbit. Pharmaceutical Research. 10(5). 750–756. 31 indexed citations
17.
Harten, J. Van, et al.. (1993). Pharmacokinetics of Fluvoxamine Maleate in Patients with Liver Cirrhosis after Single-Dose Oral Administration. Clinical Pharmacokinetics. 24(2). 177–182. 31 indexed citations
18.
Ammoury, Nazih, Hatem Fessi, Jean‐Philippe Devissaguet, M Dubrasquet, & Simon Benita. (1991). Jejunal Absorption, Pharmacological Activity, and Pharmacokinetic Evaluation of Indomethacin-Loaded Poly(d,l-Lactide) and Poly(Isobutyl-Cyanoacrylate) Nanocapsules in Rats. Pharmaceutical Research. 8(1). 101–105. 57 indexed citations
19.
Ammoury, Nazih, Hatem Fessi, Jean‐Philippe Devissaguet, et al.. (1990). Effect on Cerebral Blood Flow of Orally Administered Indomethacin-loaded Poly(isobutylcyanoacrylate) and Poly(DL-lactide) Nanocapsules. Journal of Pharmacy and Pharmacology. 42(8). 558–561. 10 indexed citations
20.
Leclerc, Bernard, et al.. (1989). In situ determination of the diffusion coefficient of a solute in a gel system using a radiotracer. Journal of Controlled Release. 9(2). 159–168. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026